KLS-13019

Overview

KLS-13019 is an orally active GPR55 receptor antagonist and a structural analogue of cannabidiol (CBD). It can prevent and reverse chemotherapy-induced peripheral neuropathy (CIPN) in a dose-dependent manner in rats.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > GPR55

Product Information

• Catalog No.: HY-123239
• CAS No.: 1801243-39-9
• Molecular Formula: C22H29NO3
• Molecular Weight: 355.47
• Purity: 98.03%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5 mg/mL (14.07 mM); Clear solution
• Availability: In-stock

Source

Original product source